Sydney. Australia’s newest purpose-built Phase 1 unit
Designed to accelerate early-phase delivery with scalable capacity and high-performance execution.
Strategically located within the North Shore Health Hub in St Leonards, Nucleus Network Sydney is co-located within the Royal North Shore Hospital precinct, providing access to specialist physicians, outpatient services, diagnostics and emergency support.
Purpose-built for complex and first-in-human studies, the Sydney facility has been designed to support diverse dosing strategies and a broad range of early-phase clinical pharmacology studies.
Purpose-built for complex early-phase success
Nucleus Network Sydney has been designed to accelerate early-phase delivery with scalable capacity and high-performance execution for complex and first-in-human studies.
Purpose-built for complex and first-in-human studies, the Sydney facility has been designed to support diverse dosing strategies and a broad range of early-phase clinical pharmacology studies.
The facility is established with deep early-phase expertise and reliable first-in-human delivery across complex study designs.
Located within the Royal North Shore Hospital precinct, sponsors have access to specialist physicians, diagnostics, emergency support and a world-class health and research ecosystem. Capabilities also include advanced pharmacology procedures and bioanalytical support delivered through onsite specialist partners.
Fast facts
41
Beds
Opening Capacity (expandable to 70 beds)
Royal North Shore Hospital precinct
Co-Location
First-in-Human, Drug-Drug Interaction (DDI), Ethnopharmacology (Bridging Studies), Biosimilar, TQT, Vaccine
Specialisation
Oral, Intradermal, Transdermal, Intravenous, Inhaled and Subcutaneous
Dosing Capabilities
Advanced Pharmacology and Bioanalytical support
Onsite Specialist Partners
5.6 million Greater Sydney population
Participant Access
Why Sydney?
Connected to one of Australia’s leading healthcare precincts
- Co-located within the 600-bed Royal North Shore Hospital precinct
- Seamless access to specialist physicians, outpatient services, diagnostics and emergency support
- On-site access to anaesthetic, imaging, respiratory and gastroenterology specialists
- Advanced pharmacology procedures and bioanalytical support delivered through onsite specialist partners
- Designed to support oral, intradermal, transdermal, intravenous, inhaled and subcutaneous administration
- Close proximity to Royal North Shore Hospital provides access to a world-class health and research ecosystem, reinforcing confidence in quality, expertise and opportunities for collaborative growth.
Focused experience across core early-phase areas
- First-in-Human (Healthy & Patient)
- Drug-Drug Interaction (DDI)
- Ethnopharmacology (Bridging Studies)
- Biosimilar
- Thorough QT (TQT)
- Vaccines
What sponsors can expect at our Sydney site
- Opening capacity of 41 beds with expansion to 70 beds
- Facility designed to support diverse dosing strategies
- Oral, intravenous, inhaled, intradermal, transdermal and subcutaneous administration
- Access to specialist physicians, outpatient services, diagnostics and emergency support
- Advanced pharmacology procedures and bioanalytical support delivered through onsite specialist partners
- On-site access to anaesthetic, imaging, respiratory and gastroenterology specialists
- Supported by experienced leadership across clinical operations, medical oversight, pharmaceutical services, laboratory services and project delivery.
Ready to launch your next study in Sydney
Whether you’re planning a first-in-human study or a complex clinical pharmacology programme, Nucleus Network Sydney provides a purpose-built early-phase facility located within the Royal North Shore Hospital precinct and supported by experienced clinical, medical and operational leadership.
